Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340585 · ClinicalTrials.gov registry record · NA
Neuroform Atlas Stent System Study
A NA study of Intracranial Aneurysm, sponsored by Stryker Neurovascular.
- Completed
- Registry status
- NA
- Development phase
- 298
- Enrollment target
- 20
- Study locations
NCT02340585: Completed NA study of Intracranial Aneurysm, sponsored by Stryker Neurovascular.
NCT02340585 is a NA study of Intracranial Aneurysm that has completed, run by Stryker Neurovascular. The registered enrollment target is 298 participants, below the 9,175-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02340585, a NA study of Intracranial Aneurysm, has completed, sponsored by Stryker Neurovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to demonstrate effectiveness and safety of the Neuroform Atlas Stent System for use with bare metal embolic coils.
Primary Outcome
Any major ipsilateral stroke or neurological death
Conditions Studied
Interventions
- DEVICE Next Generation Neuroform Stent System
Study Locations (20)
Massachusetts
- Tufts Medical Center - Boston
- Beth Israel Deaconess Medical Center - Boston
- University of Massachusetts Medical School - Worcester
California
- Cedars-Sinai Medical Center - Los Angeles
- Vascular Neurology of Southern California - Thousand Oaks
Ohio
- The Cleveland Clinic Foundation - Cleveland
- Mercy Health - St. Vincent Medical Center - Toledo
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Colorado
- Radiology Imaging Associates - Englewood
Delaware
- Christiana Care Health Services - Newark
Florida
- Lyerly Neurosurgery - Jacksonville
Georgia
- WellStar Kennestone Hospital - Marietta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2015-06-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT02340585 record still lists
NCT02340585 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, below the 9,175-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Next Generation Neuroform Stent System is the first listed.
NCT02340585 names 20 study sites across 15 states, led by Massachusetts, California, Ohio.
Frequently Asked Questions
What is clinical trial NCT02340585 about?
NCT02340585 is a clinical study titled "Neuroform Atlas Stent System Study". The primary objective of this study is to demonstrate effectiveness and safety of the Neuroform Atlas Stent System for use with bare metal embolic coils.
What is the current status of trial NCT02340585?
This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2015-06-18. Estimated completion is 2022-09-30.
What conditions does trial NCT02340585 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT02340585?
The interventions under investigation include: Next Generation Neuroform Stent System (DEVICE).
Who is sponsoring clinical trial NCT02340585?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02340585 being conducted?
This trial has 20 study locations across California, Colorado, Delaware, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02340585's enrollment target sits among peer trials
298 8th of 14 higher than 7 of 14 other Intracranial Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intracranial Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
-
Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil
COMPLETED · NA
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI